Federal Register / Vol. 88, No. 212 / Friday, November 3, 2023 / Notices 75593 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2023–24344 Filed 11–2–23; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–24–0006; Docket No. CDC–2023– 

0090] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

proposed information collection project 

titled Statement in Support of 

Application for Waiver of 

Inadmissibility Under Immigration and 

Nationality Act. This information 

collection is related to waivers of 

inadmissibility on health-related 

grounds, specifically mental health 

disorders with associated harmful 

behavior. 

DATES: CDC must receive written 

comments on or before January 2, 2024. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2023– 

0090 by either of the following methods: 

• Federal eRulemaking Portal: 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road, NE, MS H21–8, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

www.regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(www.regulations.gov) or by U.S. mail to 

the address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS 

H21–8, Atlanta, Georgia 30329; 

Telephone: 404–639–7570; Email: omb@

cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

Statement in Support of Application 

for Waiver of Inadmissibility Under 

Immigration and Nationality Act (OMB 

Control No. 0920–0006, Exp. 12/31/ 

2023)—Revision—National Center for 

Emerging and Zoonotic Infectious 

Diseases (NCEZID), Centers for Disease 

Control and Prevention (CDC). 

Background and Brief Description 

The goal of this proposed collection is 

to provide Centers for Disease Control 

and Prevention (CDC) with adequate 

information to fulfill its responsibilities 

with regard to the processing of 

applications for waivers of 

inadmissibility on health-related 

grounds, specifically mental health 

disorders with associated harmful 

behaviors. Section 212 (a) of the 

Immigration and Nationality Act (INA) 

states that aliens with specific healthrelated grounds are ineligible to receive 

visas and ineligible for admission into 

the United States. The conditions are 

listed in subsections as follows: 

(i) aliens who have a communicable 

disease of public health significance, 

(iii) (I) aliens who have a physical or 

mental disorder and behavior associated 

with the disorder that may pose, or has 

posed, a threat to the property, safety, or 

welfare of the alien or others; or 

(iii) (II) aliens who have had a 

physical or mental disorder and a 

history of behavior associated with the 

disorder, which behavior has posed a 

threat to property, safety, or welfare of 

the alien or others and which behavior 

is likely to recur or lead to other 

harmful behavior. 

However, section 212(g) of the INA 

authorizes the Attorney General to 

waive certain Class A inadmissible 

health-related grounds which would 

allow an alien to overcome his/her 

inadmissibility. The CDC may provide 

consultation to the U.S. Department of 

Homeland Security (DHS) for requests 

for waivers under section 212(a)(1)(A)(i) 

or section 212(a)(1)(A)(iii)(I) or (II), as 

indicated in the regulations (8 CFR 

212.7 Waiver of certain grounds of 

excludability) if: ‘‘the alien or the alien’s 

sponsoring family member shall submit 

a statement to the consular or Service 

office. The statement must be from a 

clinic, hospital, institution, school, or 

other specialized facility or specialist in 

the United States . . . who will 

complete the evaluation and provide an 

evaluation report to the Centers for 

Disease Control and Prevention.’’ 

Waiver requests under section 

212(a)(1)(A)(i) are processed on DHS 

forms I–601 and I–602. Waiver requests 

under section 212(a)(1)(A)(iii)(I) or (II) 

are processed under CDC form 4.422–1. 

Respondents to this data collection 

include U.S. medical facilities and 

specialists who complete Part II of CDC 

form 4.422–1 for waiver applicants 

based on physical or mental disorders 

and submit the appropriate evaluation 

report. Respondents also include the 

applicant or sponsoring family member 


lotter on DSK11XQN23PROD with NOTICES1
75594 Federal Register / Vol. 88, No. 212 / Friday, November 3, 2023 / Notices 

who complete Part III of CDC form 

4.422–1 

CDC requests OMB approval for an 

estimated 33 annual burden hours. 

There is no cost to respondents other 

than their time to participate. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

Physician ........................................... CDC 4.422–1 ................................... 200 1 10/60 33 

Total ........................................... ........................................................... ........................ ........................ ........................ 33 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2023–24346 Filed 11–2–23; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–24–23AX] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled ‘‘Assessing 

Knowledge, Attitudes, and Practices 

(KAPs) of Hispanic/Latina Women of 

Reproductive Age (WRA) about Folic 

Acid Fortification and 

Supplementation’’ to the Office of 

Management and Budget (OMB) for 

review and approval. CDC previously 

published a ‘‘Proposed Data Collection 

Submitted for Public Comment and 

Recommendations’’ notice on November 

22, 2022, to obtain comments from the 

public and affected agencies. CDC 

received one comment related to the 

previous notice. This notice serves to 

allow an additional 30 days for public 

and affected agency comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

Assessing Knowledge, Attitudes, and 

Practices (KAPs) of Hispanic/Latina 

Women of Reproductive Age (WRA) 

about Folic Acid Fortification and 

Supplementation—New—National 

Center on Birth Defects and 

Developmental Disabilities (NCBDDD), 

Centers for Disease Control and 

Prevention (CDC). 

Background and Brief Description 

Consuming 400 micrograms (mcg) of 

folic acid daily in the periconceptional 

period can reduce the risk of having a 

pregnancy affected by a neural tube 

defect (NTD), a severe birth defect of the 

brain and spine. To increase the amount 

of folic acid consumed in the U.S. 

population, the U.S. Food and Drug 

Administration (FDA) mandated 

fortification of enriched cereal grain 

products with folic acid in 1998. 

Although strides have been made in 

preventing neural tube defects, ethnic 

disparities remain. Hispanic women in 

the U.S. have the highest risk of having 

a child affected by a NTD, with birth 

prevalence of approximately seven 

NTDs per 10,000 live births. In addition, 

prior studies have found that Hispanic 

women: (1) have lower levels of folate 

in their blood compared to nonHispanic white women; (2) are more 

likely than non-Hispanic white and 

non-Hispanic black women to have the 

MTHFR C677T gene variant; (3) are less 

likely to know about the benefits of folic 

acid; and (4) are less likely to get folic 

acid from fortified foods or take a 

multivitamin with folic acid in it, 

particularly those women who primarily 

speak Spanish, were born outside of the 

United States, and have lived in the 

United States for a shorter period of 

time. 

To effectively reach Hispanic women 

of reproductive age (WRA) and increase 

their knowledge and intake of folic acid 

for NTD prevention, a contemporary 

understanding of cultural factors in the 

decision-making process and how these 

women obtain information is needed. 

Previous research highlighted important 

nuances in potential cultural beliefs 

regarding folic acid. A study of Spanishspeaking Hispanic women in the 

southwest U.S. found no cultural 

barriers to incorporating folic-acid rich 

foods into their diets; however, focus 

groups of Mexican American women 

did find several cultural barriers. These 

included: (1) misperceptions of the term 

folic acid as an illegal substance, as the 

word ‘‘acid’’ is like LSD; (2) its 

importance for NTD prevention since 

their healthcare providers did not talk to 

them about folic acid; (3) its absence in 

injectable form at the pharmacy; and (4) 

mistaken belief that birth defects are not 

preventable (resulting from an act of 


lotter on DSK11XQN23PROD with NOTICES1